sparfloxacin has been researched along with Escherichia coli Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Bergmann, M; Ceylan, I; Chakraborty, T; Fijak, M; Ludwig, M; Pilatz, A; Schuppe, HC; Wagenlehner, F; Weidner, W | 1 |
| Bergmann, M; Failing, K; Johannes, S; Ludwig, M; Schiefer, HG; Weidner, W | 1 |
| di Silverio, F; Geddes, A; Guibert, J; Naber, KG | 1 |
| Feistauer, SM; Georgopoulos, A; Georgopoulos, M; Graninger, W; Pfleger, S | 1 |
1 trial(s) available for sparfloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Escherichia coli Infections; Female; Fluoroquinolones; Humans; International Cooperation; Male; Middle Aged; Quinolones; Urinary Tract Infections | 1996 |
5 other study(ies) available for sparfloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Experimental Escherichia coli epididymitis in rats: assessment of testicular involvement in a long-term follow-up.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Epididymis; Epididymitis; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Follow-Up Studies; Longitudinal Studies; Male; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testis; Time Factors; Treatment Outcome | 2015 |
Experimental Escherichia coli epididymitis in rats: a model to assess the outcome of antibiotic treatment.
Topics: Animals; Anti-Infective Agents; Epididymitis; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2002 |
Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Topics: Abscess; Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Fluoroquinolones; Half-Life; Kidney Diseases; Methicillin Resistance; Mice; Quinolones; Staphylococcal Infections | 1992 |